cefazolin has been researched along with Coronary Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Weissgerber, AJ | 1 |
Fasquel, JL; Guillou, L; Le Couls, H; Leguerrier, A; Lenormand, JP; Logeais, Y; Rioux, C; Rosat, P; Scordia, P | 1 |
1 review(s) available for cefazolin and Coronary Disease
Article | Year |
---|---|
Methylene blue for refractory hypotension: a case report.
Topics: Aged; Anaphylaxis; Anesthesia, General; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiopulmonary Bypass; Cefazolin; Coronary Artery Bypass; Coronary Disease; Enzyme Inhibitors; Guanylate Cyclase; Humans; Hypotension; Male; Methylene Blue; Nitric Oxide Synthase; Patient Selection; Treatment Outcome | 2008 |
1 other study(ies) available for cefazolin and Coronary Disease
Article | Year |
---|---|
[Prevention of mediastinitis after cardiac surgery].
Topics: Bacterial Infections; Cardiac Surgical Procedures; Cefazolin; Coronary Disease; Gram-Negative Bacteria; Heart Defects, Congenital; Heart Valve Diseases; Humans; Mediastinitis; Retrospective Studies; Staphylococcal Infections; Streptococcal Infections | 1985 |